Skip to main content
. 2015 Oct-Dec;27(4):353–359. doi: 10.5935/0103-507X.20150060

Table 3.

Potential drug-drug interactions according to their severity, documentation and clinical value

  Frequency (%)
Severity  
    Contraindicated 9 (9.18)
    Important 41 (41.84)
    Moderate 46 (46.94)
    Secondary 2 (2.04)
Documentation  
    Excellent 26 (26.53)
    Good 21 (21.43)
    Fair 51 (52.04)
Clinical value*  
    1 50 (51.02)
    2 46 (46.94)
    3 2 (2.04)
*

1: avoid combinations; 2: usually avoid combinations; 3: minimize the risk.